Zuma-23: A Global, Phase 3, Randomized Controlled Study Of Axicabtagene Ciloleucel Versus Standard Of Care As First-Line Therapy In Patients With High-Risk Large B-Cell Lymphoma
Axicabtagene Ciloleucel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Zuma-23: A Global, Phase 3, Randomized Controlled Study Of Axicabtagene Ciloleucel Versus Standard Of Care As First-Line Therapy In Patients With High-Risk Large B-Cell Lymphoma ### Output: Axicabtagene Ciloleucel